Chronic Total Occlusions (CTO): 60 Second Insights
Published: 08 March 2018
-
Views:
2186
-
Likes:
7
-
Views:
2186
-
Likes:
7
-
Up Next -
1m 4sPart 9 | Session 3 Paul Knaappen
-
53sPart 9 | Session 4 Emmanouil Brilakis
-
1m 7sPart 9 | Session 5 Patrick Serruys
-
1m 18sPart 9 | Session 6 Carlos Di Mario
-
1m 7sPart 9 | Session 7 Gerald Werner
-
37sPart 1 Ajay Kirtane Ajay J Kirtane
-
52sPart 2 | Session 1 Ajay Kirtane Ajay J Kirtane
-
1mPart 2 | Session 2 Simon Walsh Simon J Walsh
-
49sPart 2 | Session 3 Paul Knaapen Paul Knaapen
-
27sPart 2 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis
-
1m 36sPart 2 | Session 5 Carlos Di Mario Carlo Di Mario
-
55sPart 2 | Session 6 Patrick Serruys Patrick W Serruys
-
55sPart 2 | Session 7 Gerald Werner Gerald S Werner
-
25sPart 3 | Session 1 Ajay Kirtane Ajay J Kirtane
-
46sPart 3 | Session 2 Simon Walsh Simon J Walsh
-
1mPart 3 | Session 3 Paul Knaapen Paul Knaapen
-
35sPart 3 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis
-
1m 9sPart 3 | Session 5 Carlos Di Mario Carlo Di Mario
-
57sPart 3 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 12sPart 3 | Session 7 Gerald Werner Gerald S Werner
-
46sPart 4 | Session 1 Ajay Kirtane
-
1m 6sPart 4 | Session 2 Simon Walsh Simon J Walsh
-
1m 7sPart 4 | Session 3 Paul Knaapen Paul Knaapen
-
46sPart 4 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis
-
1m 11sPart 4 | Session 5 Patrick Serruys Patrick W Serruys
-
1m 24sPart 4 | Session 6 Gerald Werner Gerald S Werner
-
38sPart 5 | Session 1 Ajay Kirtane Ajay J Kirtane
-
46sPart 5 | Session 2 Simon Walsh Simon J Walsh
-
55sPart 5 | Session 3 Paul Knaapen Paul Knaapen
-
41sPart 5 | Session 4 Emmanouil Birlakis Emmanouil S Brilakis
-
56sPart 5 | Session 5 Carlos Di Mario Carlo Di Mario
-
50sPart 5 | Session 6 Patrick Serruys Patrick W Serruys
-
47sPart 5 | Session 7 Gerald Werner Gerald S Werner
-
42sPart 6 | Session 1 Ajay Kirtane Ajay J Kirtane
-
1m 1sPart 6 | Session 2 Simon Walsh Simon J Walsh
-
1m 2sPart 6 | Session 3 Paul Knaapen Paul Knaapen
-
35sPart 6 | Session 4 Emmanouil Birkalis Emmanouil S Brilakis
-
40sPart 6 | Session 5 Carlos Di Mario Carlo Di Mario
-
1m 18sPart 6 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 7sPart 6 | Session 7 Gerald Werner Gerald S Werner
-
57sPart 7 | Session 1 Ajay Kirtane Ajay J Kirtane
-
1m 15sPart 7 | Session 2 Simon Walsh Simon J Walsh
-
1m 5sPart 7 | Session 3 Paul Knaapen Paul Knaapen
-
49sPart 7 | Session 4 Emmanouil Birkalis Emmanouil S Brilakis
-
1m 25sPart 7 | Session 5 Carlos Di Mario Carlo Di Mario
-
1m 36sPart 7 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 24sPart 7 | Session 7 Gerald Werner Gerald S Werner
-
45sPart 8 | Session 1 Ajay Kirtane Ajay J Kirtane
-
37sPart 8 | Session 2 Simon Walsh Simon J Walsh
-
1mPart 8 | Session 3 Paul Knaapen Paul Knaapen
-
37sPart 8 | Session 4 Emmanouil Birlakis Emmanouil S Brilakis
-
1m 4sPart 8 | Session 5 Carlos Di Mario Carlo Di Mario
-
1m 5sPart 8 | Session 6 Patrick Serruys Patrick W Serruys
-
1m 7sPart 8 | Session 7 Gerald Werner Gerald S Werner
-
48sPart 9 | Session 1 Ajay Kirtane Ajay J Kirtane
Overview
A series of 60-second interviews where Ajay Kirtane, Simon Walsh, Paul Knappen, Emmanouil Brilakis, Carlos Di Mario, Partick Serruys and Gerald Werner provide their thoughts on CTOs.
More from this programme
Part 1
Are CTOs important to the management of angina in your patients?
| 1 session | |
| Ajay Kirtane | Watch now |
Part 2
What trials are needed to advance the CTO field?
Part 3
What is your preferred imaging modality for CTOs?
Part 4
What is your preferred CTO wire strategy, and why?
Part 5
What is the biggest advance in CTO treatment in the past 5 years?
Part 6
What devices should be developed to further advance CTO management?
Part 7
The data for CTO is mixed, with clinical trials showing no clear benefit, should we keep on doing CTO's?
Part 8
Retrograde or anterograde? What is your preferred strategy?
Part 9
